Improvement in Pulmonary Function in Mitral Stenosis after Percutaneous Transvenous Mitral Commissurotomy
Takao Yoshioka(National Cerebral and Cardiovascular Center), Seiki Nagata(National Cerebral and Cardiovascular Center), Fuminobu Ishikura(National Cerebral and Cardiovascular Center), Norifumi Nakanishi(National Cerebral and Cardiovascular Center), Takeyoshi Kunieda(National Cerebral and Cardiovascular Center), Sumpei Okubo(National Cerebral and Cardiovascular Center)
Cited by 21
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404